Subscribe to Search results

The Haemophilia Society wrote to Lord Morris of Manchester taking issue with Baroness Hayman's answer to his question in parliament on the basis that it did not represent an accurate explanation of the Government's decision in 1987 to introduce a special payments scheme for those infected with HIV.

Published on:

Lord Philip Hunt took over from Baroness Hayman in July 1999 and in September attended a briefing with officials regarding the Hepatitis C issue.

Published on:

Lord Philip Hunt was advised that ministers had taken a clear decision not to award a special payment scheme but that there was continued unhappiness and lobbying.

Published on:

A line to take drafted for ministers sought to justify the difference between Hepatitis C and HIV on the basis that the decision to make special payments for the latter was an exception by the previous Government "in circumstances where the only prospect for these patients was early death."

Published on:

In response to Lord Hunt's request for an outline costing of a hardship fund for people with haemophilia infected with Hepatitis C, the advice was that such a fund would be unlikely to be acceptable.

Published on:

Charles Lister, providing advice to Lord Hunt regarding the Hepatitis C litigation against the National Blood Authority, noted that settlement of that litigation (or an award of damages by the court) would give rise to "inevitable claims of inequity from the Haemophilia Society".

Published on:

Lord Hunt noted a clear and defendable distinction between settlement of litigation and the Government's continued refusal to compensate people with haemophilia infected with HCV through blood products on the basis of non-negligent harm.

Published on:

In October 2000, Lord Hunt sought advice on what could be offered in terms of a package of care for victims of HCV, as noted in an email chain from Sue Cartwright to Charles Lister.

Published on:

In a memo from Jane Verity and Charles Lister to Sue Cartwright, officials provided Lord Hunt a co-ordinated approach to problems associated with Hepatitis C treatment.

Published on:

Charles Lister in his statement to the Inquiry stated that Sandra Falconer noted that the Scottish Executive was seeking to maintain the common UK position.

Published on:

Charles Lister in his statement noted that campaigners from Manor House and Haemophilia Action UK staged a protest march demanding compensation.

Published on:

Charles Lister responded to questions by Yvette Cooper noting that it would be difficult to make payments to those with haemophilia without making payments to those infected via blood transfusion.

Published on:

In early July 2001, Yvette Cooper approved an amended line to take regarding ministers "reviewing the case for compensation".

Published on:

At a meeting of SNBTS and hemophilia directors Professor Ludlam explained 16 haemophilia patients treated with SNBTS Factor 8 had been infected with HTLV 3.

Published on:

At a meeting of SNBTS and heamophilia directors Dr Forbes spoke of findings relating to HTLV 3 antibody seroconversion in a comparative study of haemophilia patients in Glasgow and Denmark.

Published on:

At a meeting of SNBTS and haemophilia directors Dr Brenda Gibson reported five out of ten patients tested at the Royal Hospital for Sick Children (Yorkhill) were HIV positive.

Published on:

At a meeting of SNBTS and haemophilia directors it was agreed that patients should be informed about the recent findings in relation to patients with haemophilia being infected with HIV before additional publicity was given.

Published on:

In 1983 there was an increase in the use of commercial concentrates (200,000 units of Factorate for home treatment), although NHS concentrates remained the mainstay of treatment at the Glasgow Haemophilia Centre.

Published on:

In 1984, the use of commercial concentrates dropped again at the Glasgow Haemophilia Centre.

Published on:

A study of immune abnormalities in patients with severe haemophilia resulted in the publication in of a paper entitled "Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate"? The study concluded that Scottish patients had immunological abnormalities similar to those in their US counterparts.

Published on: